Interestingly, several cancers which did not show significant effects for CD274 for the patient cohorts selected demonstrated significant impact of PDCD1 expression on patient survival, including bladder cancer, esophageal cancer, and head and neck cancer. This evidence concerns the gene PDCD1 and urinary bladder cancer.